On February 20, 2026 enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral genetic medicines company, reported that management will participate in the following investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 36th Annual Healthcare Life Sciences Conference
Date: Thursday, February 26, 2026
Format: Presentation
Time: 1:20 p.m. ET

Leerink Partners 2026 Global Healthcare Conference
Date: Monday, March 9, 2026
Format: Fireside chat
Time: 8:00 a.m. ET

Barclays 28th Annual Global Healthcare Conference
Date: Tuesday, March 10, 2026
Format: Fireside chat
Time: 9:00 a.m. ET

Citizens Life Sciences Conference
Date: Wednesday, March 11, 2026
Format: Fireside chat
Time: 1:40 p.m. ET

A live webcast of these events can be accessed on the "Events and Presentations" page under the "Investors" section of the enGene website at www.engene.com and will be archived there for 90 days.

(Press release, enGene, FEB 20, 2026, View Source [SID1234662827])